These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
756 related articles for article (PubMed ID: 21836485)
41. Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma. Morimoto T; Mitomi H; Saito T; Takahashi M; Murakami T; Sakamoto N; Yao T; Watanabe S J Gastroenterol Hepatol; 2014 Jun; 29(6):1192-9. PubMed ID: 24612059 [TBL] [Abstract][Full Text] [Related]
42. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. Gibson JA; Hahn HP; Shahsafaei A; Odze RD Am J Surg Pathol; 2011 May; 35(5):742-9. PubMed ID: 21490447 [TBL] [Abstract][Full Text] [Related]
43. Pathogenesis and management of serrated polyps: current status and future directions. Anderson JC Gut Liver; 2014 Nov; 8(6):582-9. PubMed ID: 25368744 [TBL] [Abstract][Full Text] [Related]
44. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum. Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095 [TBL] [Abstract][Full Text] [Related]
45. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
46. Epidemiology of goblet cell and microvesicular hyperplastic polyps. Qazi TM; O'Brien MJ; Farraye FA; Gould RW; Chen CA; Schroy PC Am J Gastroenterol; 2014 Dec; 109(12):1922-32. PubMed ID: 25350766 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710 [TBL] [Abstract][Full Text] [Related]
49. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. Hawkins NJ; Ward RL J Natl Cancer Inst; 2001 Sep; 93(17):1307-13. PubMed ID: 11535705 [TBL] [Abstract][Full Text] [Related]
50. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Rosty C; Young JP; Walsh MD; Clendenning M; Walters RJ; Pearson S; Pavluk E; Nagler B; Pakenas D; Jass JR; Jenkins MA; Win AK; Southey MC; Parry S; Hopper JL; Giles GG; Williamson E; English DR; Buchanan DD Mod Pathol; 2013 Jun; 26(6):825-34. PubMed ID: 23348904 [TBL] [Abstract][Full Text] [Related]
51. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563 [TBL] [Abstract][Full Text] [Related]
52. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix. Yantiss RK; Panczykowski A; Misdraji J; Hahn HP; Odze RD; Rennert H; Chen YT Am J Surg Pathol; 2007 Nov; 31(11):1742-53. PubMed ID: 18059232 [TBL] [Abstract][Full Text] [Related]
54. Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas. Pai RK; Mackinnon AC; Joseph L; Noffsinger A; Hart J Am J Surg Pathol; 2010 Mar; 34(3):355-63. PubMed ID: 20118768 [TBL] [Abstract][Full Text] [Related]
55. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Kim YH; Kakar S; Cun L; Deng G; Kim YS Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261 [TBL] [Abstract][Full Text] [Related]
56. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Chan TL; Zhao W; Leung SY; Yuen ST; Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809 [TBL] [Abstract][Full Text] [Related]
57. [Colorectal serrated adenoma: diagnostic criteria and clinical implications]. Rüschoff J; Aust D; Hartmann A Verh Dtsch Ges Pathol; 2007; 91():119-25. PubMed ID: 18314605 [TBL] [Abstract][Full Text] [Related]
58. Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities. Silva P; Albuquerque C; Lage P; Fontes V; Fonseca R; Vitoriano I; Filipe B; Rodrigues P; Moita S; Ferreira S; Sousa R; Claro I; Nobre Leitão C; Chaves P; Dias Pereira A Int J Mol Med; 2016 Sep; 38(3):687-702. PubMed ID: 27430658 [TBL] [Abstract][Full Text] [Related]
59. Molecular characteristics of colorectal hyperplastic polyp subgroups. Ünlü M; Uzun E; Bengi G; Sağol Ö; Sarıoğlu S Turk J Gastroenterol; 2020 Aug; 31(8):573-580. PubMed ID: 32915145 [TBL] [Abstract][Full Text] [Related]
60. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]